Katy Hunter is a seasoned professional in global regulatory affairs, currently serving as the Director of Global Regulatory at ICON plc since July 2021. Prior experience includes roles as Associate Director of Global Regulatory Clinical Services at ICON plc and Associate Director of Global Regulatory Affairs at PRA Health Sciences, where Katy worked from April 2013 to July 2021. Earlier in the career, Katy held positions at INC Research, Charles River Laboratories, and AstraZeneca, gaining experience as Regulatory Lead, Study Director, and Safety Pharmacologist, respectively. Katy Hunter earned a Bachelor of Science (BSc) in Physiology from St. Andrews University between 1991 and 1995.
This person is not in any teams
This person is not in any offices